Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
depression
4
×
life sciences
major depressive disorder
4
×
national blog main
biotech
boston
boston blog main
boston top stories
national top stories
blackstone group
clinical trials
david goldstein
epilepsy
essential tremor
fda
kiran reddy
neuroscience
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
sage therapeutics
startups
steven petrou
venture capital
510k
aligos therapeutics
angel investing
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
biotech ipos
blackstone life sciences
blepharitis
brain
brexanalone
cavion
cephalgia
What
depression
disorder
drugs
medicines
praxis
precision
research
adds
aims
antonio
approval
backed
biotechs
brexanalone
cause
central
ceo
cns
drug
emerged
epilepsy
fda
field
funding
genes
genetic
hits
hopes
hour
imaging
improve
infusion
ipos
kept
leads
links
magnetic
marcio
mark
medical
Language
unset
Current search:
" major depressive disorder "
×
depression
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
6 years ago
San Antonio Startup Adds Funding to Treat PTSD with Magnetic Field